Belkind-Gerson Jaime, Hotta Ryo, Whalen Michael, Nayyar Naema, Nagy Nandor, Cheng Lily, Zuckerman Aaron, Goldstein Allan M, Dietrich Jorg
Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Pediatric Neurogastroenterology Program, Massachusetts General Hospital, Harvard Medical School, 175 Cambridge St #575, Boston, MA, 02114, USA.
BMC Neurosci. 2016 Jan 25;17:5. doi: 10.1186/s12868-016-0238-y.
A major area of unmet need is the development of strategies to restore neuronal network systems and to recover brain function in patients with neurological disease. The use of cell-based therapies remains an attractive approach, but its application has been challenging due to the lack of suitable cell sources, ethical concerns, and immune-mediated tissue rejection. We propose an innovative approach that utilizes gut-derived neural tissue for cell-based therapies following focal or diffuse central nervous system injury.
Enteric neuronal stem and progenitor cells, able to differentiate into neuronal and glial lineages, were isolated from the postnatal enteric nervous system and propagated in vitro. Gut-derived neural progenitors, genetically engineered to express fluorescent proteins, were transplanted into the injured brain of adult mice. Using different models of brain injury in combination with either local or systemic cell delivery, we show that transplanted enteric neuronal progenitor cells survive, proliferate, and differentiate into neuronal and glial lineages in vivo. Moreover, transplanted cells migrate extensively along neuronal pathways and appear to modulate the local microenvironment to stimulate endogenous neurogenesis.
Our findings suggest that enteric nervous system derived cells represent a potential source for tissue regeneration in the central nervous system. Further studies are needed to validate these findings and to explore whether autologous gut-derived cell transplantation into the injured brain can result in functional neurologic recovery.
尚未满足的一个主要需求领域是开发恢复神经网络系统和恢复神经疾病患者脑功能的策略。基于细胞的疗法仍然是一种有吸引力的方法,但其应用一直面临挑战,原因包括缺乏合适的细胞来源、伦理问题以及免疫介导的组织排斥反应。我们提出一种创新方法,即在局灶性或弥漫性中枢神经系统损伤后,利用肠道来源的神经组织进行基于细胞的治疗。
从出生后肠道神经系统中分离出能够分化为神经元和胶质细胞谱系的肠道神经元干细胞和祖细胞,并在体外进行增殖培养。将经过基因工程改造以表达荧光蛋白的肠道来源神经祖细胞移植到成年小鼠的受伤大脑中。结合局部或全身细胞递送使用不同的脑损伤模型,我们发现移植的肠道神经元祖细胞在体内能够存活、增殖并分化为神经元和胶质细胞谱系。此外,移植细胞沿着神经通路广泛迁移,并且似乎能够调节局部微环境以刺激内源性神经发生。
我们的研究结果表明,肠道神经系统来源的细胞是中枢神经系统组织再生的潜在细胞来源。需要进一步研究来验证这些发现,并探索将自体肠道来源的细胞移植到受伤大脑中是否能够导致功能性神经恢复。